Foster Dykema Cabot & Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$273K Hold
3,200
0.02% 101
2025
Q4
$253K Sell
3,200
-833
-21% -$65.3K 0.02% 111
2025
Q3
$322K Buy
4,033
+220
+6% +$18.8K 0.02% 105
2025
Q2
$347K Hold
3,813
0.02% 99
2025
Q1
$357K Sell
3,813
-112
-3% -$10K 0.03% 86
2024
Q4
$357K Sell
3,925
-1,999
-34% -$191K 0.03% 96
2024
Q3
$615K Buy
5,924
+1,209
+26% +$123K 0.05% 70
2024
Q2
$458K Buy
4,715
+21
+0.4% +$1.94K 0.04% 67
2024
Q1
$423K Buy
4,694
+228
+5% +$19.3K 0.04% 69
2023
Q4
$356K Buy
+4,466
New +$336K 0.04% 67

Other funds holding CL

Foster Dykema Cabot & Partners's CL Position: Q1 2026 in Review

Foster Dykema Cabot & Partners held its Colgate-Palmolive (CL) position steady in Q1 2026 at 3,200 shares worth $273K. The position accounts for 0.02% of the portfolio, ranked #101.

Foster Dykema Cabot & Partners first reported a position in CL in Q4 2023 and has held it in 10 quarters since. The position peaked at $615K in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Foster Dykema Cabot & Partners held 3,200 shares of Colgate-Palmolive worth $273K as of Q1 2026.
  • Foster Dykema Cabot & Partners left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.02% of Foster Dykema Cabot & Partners's portfolio in Q1 2026, its #101 holding.
  • Foster Dykema Cabot & Partners first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 10 quarters since.
  • Foster Dykema Cabot & Partners's Colgate-Palmolive position peaked at $615K in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q1 2026, filed 14 May 2026.